JXHL1600077 | 盐酸达拉他韦 | daclatasvir dihydrochloride | Active ingredient | Chemical Drugs(5.1) | Import Drug Application | 2016-08-11 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | In Review | 2018-07-18 | view |
JXSS1900069 | 纳武利尤单抗注射液 | Nivolumab | Injection | Biological Products | Import Drug Application | 2019-12-26 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2021-07-05 | view |
JXHL1100254 | 丙氨酸布立尼布片 | brivanib alaninate | Tablet | Chemical Drugs | Import Drug Application | 2011-08-02 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2012-04-05 | view |
JXHL1800066 | BMS-986205片 | BMS-986205 | Tablet | Chemical Drugs(1) | Import Drug Application | 2018-06-19 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2018-08-28 | view |
JXHL0700060 | 阿哌沙班片 | apixaban | Tablet | Chemical Drugs(1.1) | Import Drug Application | 2007-03-19 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2007-11-12 | view |
JXSL1700042 | Nivolumab注射液 | Nivolumab | Injection | Biological Products | Import Drug Application | 2017-07-31 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2017-11-23 | view |
JXHS1600062 | 盐酸达拉他韦片 | daclatasvir dihydrochloride | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2016-11-07 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2017-06-21 | view |
JXSL2100005 | Relatlimab/Nivolumab固定剂量复方注射液 | nivolumab;relatlimab | Injection | Biological Products(1) | Import Drug Application | 2021-01-09 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | In Review | 2021-01-08 | view |
JXSL1300030 | 伊匹木单抗注射液 | Ipilimumab | Injection | Biological Products | Import Drug Application | 2013-04-28 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2015-07-27 | view |
JXHL1900022 | BMS-986165 | deucravacitinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2019-02-02 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | In Review | 2019-02-01 | view |
JYHB0701203 | 醋酸甲地孕酮口服混悬液 | megestrol acetate | Suspension | Chemical Drugs | Supplementary Application | 2007-12-19 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2009-06-19 | view |
H20020022 | 卡铂注射液 | carboplatin | Injection | Chemical Drugs | Import Drug Application | 2002-02-26 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Approval Completed-Pending Certificated | | view |
JXSL1700001 | 伊匹木单抗注射液 | Ipilimumab | Injection | Biological Products | Import Drug Application | 2017-01-22 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2017-05-25 | view |
JXHL1600015 | 盐酸达拉他韦片 | daclatasvir dihydrochloride | Tablet | Chemical Drugs | Import Drug Application | 2016-02-16 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2016-10-31 | view |
JYHB1901304 | 阿哌沙班片 | apixaban | Tablet | Chemical Drugs | Supplementary Application | 2019-11-09 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2020-01-06 | view |
JXSL1100014 | Ipilimumab注射液 | Ipilimumab | Injection | Biological Products | Import Drug Application | 2011-03-16 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2013-07-08 | view |
J0401253 | 紫杉醇注射液 | Paclitaxel | Injection | Chemical Drugs | Supplementary Application | 2004-07-07 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2005-02-18 | view |
JYSB1700107 | 伊匹木单抗注射液 | Ipilimumab | Injection | Biological Products | Supplementary Application | 2017-05-27 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2017-09-26 | view |
JXSL1600047 | Nivolumab注射液 | Nivolumab | Injection | Biological Products | Import Drug Application | 2016-09-12 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2017-03-27 | view |
JXHB2000061 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2020-12-18 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | In Review | 2020-12-17 | view |